$URGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in UroGen Pharma Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in UroGen Pharma Ltd.. Get notifications about new insider transactions in UroGen Pharma Ltd. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 09 2021 | URGN | UroGen Pharma Ltd. | Cohen Fred E | Director | Option Exercise | A | 17.98 | 10,000 | 179,800 | 10,000 | |
| Jun 09 2021 | URGN | UroGen Pharma Ltd. | BUTITTA CYNTHIA M | Director | Option Exercise | A | 17.98 | 10,000 | 179,800 | 10,000 | |
| Jun 09 2021 | URGN | UroGen Pharma Ltd. | Holden Stuart | Director | Option Exercise | A | 17.98 | 10,000 | 179,800 | 10,000 | |
| May 04 2021 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | M | 0.00 | 500 | 0 | 3,500 | |
| May 04 2021 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Sell | S | 20.00 | 243 | 4,860 | 21,132 | 21.4 K to 21.1 K (-1.14 %) |
| May 04 2021 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Buy | M | 0.00 | 500 | 0 | 21,375 | 20.9 K to 21.4 K (+2.40 %) |
| Apr 22 2021 | URGN | UroGen Pharma Ltd. | Belldegrun Arie | Director | Option Exercise | M | 5.00 | 3,241 | 16,205 | 0 | |
| Apr 22 2021 | URGN | UroGen Pharma Ltd. | Belldegrun Arie | Director | Buy | M | 5.00 | 3,241 | 16,205 | 245,452 | 242.2 K to 245.5 K (+1.34 %) |
| Apr 22 2021 | URGN | UroGen Pharma Ltd. | Nussbaum Ran | Director | Option Exercise | M | 5.00 | 1,030 | 5,150 | 0 | |
| Apr 22 2021 | URGN | UroGen Pharma Ltd. | Nussbaum Ran | Director | Buy | M | 5.00 | 1,030 | 5,150 | 1,465,199 | 1.5 M to 1.5 M (+0.07 %) |
| Feb 02 2021 | URGN | UroGen Pharma Ltd. | Henderson Molly | Chief Financial Off ... | Option Exercise | A | 0.00 | 2,000 | 0 | 2,000 | |
| Feb 02 2021 | URGN | UroGen Pharma Ltd. | Henderson Molly | Chief Financial Off ... | Option Exercise | A | 22.07 | 6,000 | 132,420 | 6,000 | |
| Feb 02 2021 | URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
| Feb 02 2021 | URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | Option Exercise | A | 22.07 | 8,000 | 176,560 | 8,000 | |
| Feb 02 2021 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Off ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
| Feb 02 2021 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Off ... | Option Exercise | A | 22.07 | 150,000 | 3,310,500 | 150,000 | |
| Feb 02 2021 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
| Feb 02 2021 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | A | 22.07 | 21,000 | 463,470 | 21,000 | |
| Feb 02 2021 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | M | 0.00 | 2,000 | 0 | 4,000 | |
| Feb 02 2021 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Sell | S | 22.07 | 1,076 | 23,747 | 20,755 | 21.8 K to 20.8 K (-4.93 %) |
| Feb 02 2021 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Buy | M | 0.00 | 2,000 | 0 | 21,831 | 19.8 K to 21.8 K (+10.09 %) |
| Jan 26 2021 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | M | 0.00 | 208 | 0 | 834 | |
| Jan 26 2021 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Sell | S | 22.12 | 100 | 2,212 | 19,831 | 19.9 K to 19.8 K (-0.50 %) |
| Jan 26 2021 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Buy | M | 0.00 | 208 | 0 | 19,931 | 19.7 K to 19.9 K (+1.05 %) |
| Dec 15 2020 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Off ... | Buy | P | 18.50 | 10,000 | 185,000 | 229,117 | 219.1 K to 229.1 K (+4.56 %) |
| Dec 07 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | M | 0.00 | 1,042 | 0 | 0 | |
| Dec 07 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Sell | S | 19.85 | 662 | 13,141 | 19,723 | 20.4 K to 19.7 K (-3.25 %) |
| Dec 07 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Buy | M | 0.00 | 1,042 | 0 | 20,385 | 19.3 K to 20.4 K (+5.39 %) |
| Dec 04 2020 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Off ... | Option Exercise | M | 0.00 | 61,652 | 0 | 114,496 | |
| Dec 04 2020 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Off ... | Buy | M | 0.00 | 61,652 | 0 | 219,117 | 157.5 K to 219.1 K (+39.15 %) |
| Oct 28 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | M | 0.00 | 208 | 0 | 1,042 | |
| Oct 28 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Sell | S | 20.95 | 101 | 2,116 | 19,343 | 19.4 K to 19.3 K (-0.52 %) |
| Oct 28 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Buy | M | 0.00 | 208 | 0 | 19,444 | 19.2 K to 19.4 K (+1.08 %) |
| Oct 16 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,000 | 0 | 4,000 | |
| Oct 16 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,084 | 0 | 2,082 | |
| Oct 16 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 833 | 0 | 1,667 | |
| Oct 16 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 21.72 | 1,017 | 22,089 | 10,405 | 11.4 K to 10.4 K (-8.90 %) |
| Oct 16 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 21.82 | 407 | 8,882 | 11,422 | 11.8 K to 11.4 K (-3.44 %) |
| Oct 16 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 21.80 | 976 | 21,276 | 11,829 | 12.8 K to 11.8 K (-7.62 %) |
| Oct 16 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Buy | M | 0.00 | 4,917 | 0 | 12,805 | 7.9 K to 12.8 K (+62.34 %) |
| Sep 10 2020 | URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Sep 10 2020 | URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | Option Exercise | A | 21.38 | 60,000 | 1,282,800 | 60,000 | |
| Sep 08 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | M | 0.00 | 1,041 | 0 | 1,042 | |
| Sep 08 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Sell | S | 20.20 | 348 | 7,030 | 19,236 | 19.6 K to 19.2 K (-1.78 %) |
| Sep 08 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Buy | M | 0.00 | 1,041 | 0 | 19,584 | 18.5 K to 19.6 K (+5.61 %) |
| Sep 01 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,042 | 0 | 4,166 | |
| Sep 01 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 22.82 | 509 | 11,615 | 7,888 | 8.4 K to 7.9 K (-6.06 %) |
| Sep 01 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Buy | M | 0.00 | 1,042 | 0 | 8,397 | 7.4 K to 8.4 K (+14.17 %) |
| Jul 28 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 417 | 0 | 2,500 | |
| Jul 28 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 23.51 | 141 | 3,315 | 7,355 | 7.5 K to 7.4 K (-1.88 %) |
| Jul 28 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Buy | M | 0.00 | 417 | 0 | 7,496 | 7.1 K to 7.5 K (+5.89 %) |
| Jul 28 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | M | 0.00 | 209 | 0 | 1,250 | |
| Jul 28 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Sell | S | 23.51 | 70 | 1,646 | 18,543 | 18.6 K to 18.5 K (-0.38 %) |
| Jul 28 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Buy | M | 0.00 | 209 | 0 | 18,613 | 18.4 K to 18.6 K (+1.14 %) |
| Jun 10 2020 | URGN | UroGen Pharma Ltd. | Tomasello Shawn | Director | Option Exercise | A | 28.24 | 10,000 | 282,400 | 10,000 | |
| Jun 10 2020 | URGN | UroGen Pharma Ltd. | Nussbaum Ran | Director | Option Exercise | A | 28.24 | 10,000 | 282,400 | 10,000 | |
| Jun 10 2020 | URGN | UroGen Pharma Ltd. | Holden Stuart | Director | Option Exercise | A | 28.24 | 10,000 | 282,400 | 10,000 | |
| Jun 10 2020 | URGN | UroGen Pharma Ltd. | FALBERG KATHRYN E | Director | Option Exercise | A | 28.24 | 10,000 | 282,400 | 10,000 | |
| Jun 10 2020 | URGN | UroGen Pharma Ltd. | Cohen Fred E | Director | Option Exercise | A | 28.24 | 10,000 | 282,400 | 10,000 | |
| Jun 10 2020 | URGN | UroGen Pharma Ltd. | BUTITTA CYNTHIA M | Director | Option Exercise | A | 28.24 | 10,000 | 282,400 | 10,000 | |
| Jun 10 2020 | URGN | UroGen Pharma Ltd. | Belldegrun Arie | Director | Option Exercise | A | 28.24 | 10,000 | 282,400 | 10,000 | |
| Jun 05 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | M | 0.00 | 1,042 | 0 | 2,083 | |
| Jun 05 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Sell | S | 27.51 | 349 | 9,602 | 18,404 | 18.8 K to 18.4 K (-1.86 %) |
| Jun 05 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Buy | M | 0.00 | 1,042 | 0 | 18,753 | 17.7 K to 18.8 K (+5.88 %) |
| May 20 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,041 | 0 | 5,208 | |
| May 20 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 25.07 | 358 | 8,975 | 7,079 | 7.4 K to 7.1 K (-4.81 %) |
| May 20 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Buy | M | 0.00 | 1,041 | 0 | 7,437 | 6.4 K to 7.4 K (+16.28 %) |
| May 14 2020 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Off ... | Option Exercise | M | 0.00 | 35,229 | 0 | 176,148 | |
| May 14 2020 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Off ... | Buy | M | 0.00 | 35,229 | 0 | 157,465 | 122.2 K to 157.5 K (+28.82 %) |
| Apr 28 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | M | 0.00 | 208 | 0 | 1,459 | |
| Apr 28 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Sell | S | 24.35 | 70 | 1,705 | 17,711 | 17.8 K to 17.7 K (-0.39 %) |
| Apr 28 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Buy | M | 0.00 | 208 | 0 | 17,781 | 17.6 K to 17.8 K (+1.18 %) |
| Apr 28 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 417 | 0 | 2,917 | |
| Apr 28 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 24.35 | 141 | 3,433 | 6,396 | 6.5 K to 6.4 K (-2.16 %) |
| Apr 28 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Buy | M | 0.00 | 417 | 0 | 6,537 | 6.1 K to 6.5 K (+6.81 %) |
| Apr 28 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | M | 0.00 | 417 | 0 | 2,917 | |
| Apr 28 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Sell | S | 24.35 | 145 | 3,531 | 10,084 | 10.2 K to 10.1 K (-1.42 %) |
| Apr 28 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Buy | M | 0.00 | 417 | 0 | 10,229 | 9.8 K to 10.2 K (+4.25 %) |
| Mar 04 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | M | 0.00 | 1,042 | 0 | 3,125 | |
| Mar 04 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Payment of Exercise | F | 29.50 | 345 | 10,178 | 17,573 | 17.9 K to 17.6 K (-1.93 %) |
| Mar 04 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Buy | M | 0.00 | 1,042 | 0 | 17,918 | 16.9 K to 17.9 K (+6.17 %) |
| Feb 24 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,042 | 0 | 6,249 | |
| Feb 24 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,042 | 0 | 6,249 | |
| Feb 24 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 29.68 | 360 | 10,685 | 6,120 | 6.5 K to 6.1 K (-5.56 %) |
| Feb 24 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 29.68 | 360 | 10,685 | 6,120 | 6.5 K to 6.1 K (-5.56 %) |
| Feb 24 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Buy | M | 0.00 | 1,042 | 0 | 6,480 | 5.4 K to 6.5 K (+19.16 %) |
| Feb 24 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Buy | M | 0.00 | 1,042 | 0 | 6,480 | 5.4 K to 6.5 K (+19.16 %) |
| Feb 18 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,759 | 0 | 7,037 | |
| Feb 18 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Sell | S | 28.04 | 612 | 17,160 | 9,812 | 10.4 K to 9.8 K (-5.87 %) |
| Feb 18 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Buy | M | 0.00 | 1,759 | 0 | 10,424 | 8.7 K to 10.4 K (+20.30 %) |
| Feb 04 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
| Feb 04 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | A | 29.41 | 15,000 | 441,150 | 15,000 | |
| Feb 04 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | |
| Feb 04 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | A | 29.41 | 15,000 | 441,150 | 15,000 | |
| Feb 04 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
| Feb 04 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | A | 29.41 | 15,000 | 441,150 | 15,000 | |
| Feb 04 2020 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Off ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Feb 04 2020 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Off ... | Option Exercise | A | 29.41 | 45,000 | 1,323,450 | 45,000 | |
| Jan 28 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,666 | 0 | 3,334 | |
| Jan 28 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 29.28 | 667 | 19,530 | 4,438 | 5.1 K to 4.4 K (-13.07 %) |
| Jan 28 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Buy | M | 0.00 | 1,666 | 0 | 5,105 | 3.4 K to 5.1 K (+48.44 %) |
| Jan 28 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,666 | 0 | 3,334 | |
| Jan 28 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Sell | S | 29.26 | 684 | 20,014 | 8,665 | 9.3 K to 8.7 K (-7.32 %) |
| Jan 28 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Buy | M | 0.00 | 1,666 | 0 | 9,349 | 7.7 K to 9.3 K (+21.68 %) |
| Jan 28 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | M | 0.00 | 833 | 0 | 1,667 | |
| Jan 28 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Sell | S | 29.15 | 322 | 9,386 | 9,177 | 9.5 K to 9.2 K (-3.39 %) |
| Jan 28 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Buy | M | 0.00 | 833 | 0 | 9,499 | 8.7 K to 9.5 K (+9.61 %) |
| Jan 07 2020 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Off ... | Option Exercise | M | 0.00 | 105,688 | 0 | 211,377 | |
| Jan 07 2020 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Off ... | Buy | M | 0.00 | 105,688 | 0 | 122,236 | 16.5 K to 122.2 K (+638.68 %) |
| Dec 05 2019 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | M | 0.00 | 1,042 | 0 | 4,167 | |
| Dec 05 2019 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Payment of Exercise | F | 31.69 | 343 | 10,870 | 8,666 | 9 K to 8.7 K (-3.81 %) |
| Dec 05 2019 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Buy | M | 0.00 | 1,042 | 0 | 9,009 | 8 K to 9 K (+13.08 %) |
| Dec 05 2019 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | M | 0.00 | 1,042 | 0 | 4,167 | |
| Dec 05 2019 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Payment of Exercise | F | 31.69 | 343 | 10,870 | 8,666 | 9 K to 8.7 K (-3.81 %) |
| Dec 05 2019 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Buy | M | 0.00 | 1,042 | 0 | 9,009 | 8 K to 9 K (+13.08 %) |
| Nov 22 2019 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Off ... | Buy | P | 28.00 | 7,530 | 210,840 | 16,548 | 9 K to 16.5 K (+83.50 %) |
| Nov 22 2019 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Off ... | Buy | P | 28.00 | 7,470 | 209,160 | 9,018 | 1.5 K to 9 K (+482.56 %) |
| Nov 22 2019 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Off ... | Buy | P | 28.00 | 7,470 | 209,160 | 9,018 | 1.5 K to 9 K (+482.56 %) |
| Nov 22 2019 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,042 | 0 | 7,291 | |
| Nov 22 2019 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 28.41 | 354 | 10,057 | 3,439 | 3.8 K to 3.4 K (-9.33 %) |
| Nov 22 2019 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Buy | M | 0.00 | 1,042 | 0 | 3,793 | 2.8 K to 3.8 K (+37.88 %) |
| Nov 21 2019 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Buy | P | 28.17 | 1,960 | 55,213 | 7,967 | 6 K to 8 K (+32.63 %) |
| Nov 21 2019 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Buy | P | 28.17 | 1,960 | 55,213 | 7,967 | 6 K to 8 K (+32.63 %) |
| Nov 18 2019 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Off ... | Buy | P | 26.00 | 1,548 | 40,248 | 1,548 | 0 to 1.5 K |
| Nov 18 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,759 | 0 | 8,796 | |
| Nov 18 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Sell | S | 26.00 | 608 | 15,806 | 7,683 | 8.3 K to 7.7 K (-7.33 %) |
| Nov 18 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Buy | M | 0.00 | 1,759 | 0 | 8,291 | 6.5 K to 8.3 K (+26.93 %) |
| Sep 06 2019 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | M | 0.00 | 1,041 | 0 | 5,209 | |
| Sep 06 2019 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Sell | S | 33.92 | 343 | 11,635 | 6,007 | 6.4 K to 6 K (-5.40 %) |
| Sep 06 2019 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Buy | M | 0.00 | 1,041 | 0 | 6,350 | 5.3 K to 6.4 K (+19.61 %) |
| Aug 22 2019 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 4,167 | 0 | 8,333 | |
| Aug 22 2019 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 33.07 | 1,416 | 46,827 | 2,751 | 4.2 K to 2.8 K (-33.98 %) |
| Aug 22 2019 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Buy | M | 0.00 | 4,167 | 0 | 4,167 | 0 to 4.2 K |
| Aug 16 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,759 | 0 | 10,555 | |
| Aug 16 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Sell | S | 31.65 | 608 | 19,243 | 6,532 | 7.1 K to 6.5 K (-8.52 %) |
| Aug 16 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Buy | M | 0.00 | 1,759 | 0 | 7,140 | 5.4 K to 7.1 K (+32.69 %) |
| Jun 06 2019 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | M | 0.00 | 1,042 | 0 | 6,250 | |
| Jun 06 2019 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Payment of Exercise | F | 35.05 | 343 | 12,022 | 5,309 | 5.7 K to 5.3 K (-6.07 %) |
| Jun 06 2019 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Buy | M | 0.00 | 1,042 | 0 | 5,652 | 4.6 K to 5.7 K (+22.60 %) |
| Jun 05 2019 | URGN | UroGen Pharma Ltd. | Tomasello Shawn | Director | Option Exercise | A | 34.83 | 10,000 | 348,300 | 10,000 | |
| Jun 05 2019 | URGN | UroGen Pharma Ltd. | FALBERG KATHRYN E | Director | Option Exercise | A | 34.83 | 10,000 | 348,300 | 10,000 | |
| Jun 05 2019 | URGN | UroGen Pharma Ltd. | BUTITTA CYNTHIA M | Director | Option Exercise | A | 34.83 | 10,000 | 348,300 | 10,000 | |
| Jun 05 2019 | URGN | UroGen Pharma Ltd. | Cohen Fred E | Director | Option Exercise | A | 34.83 | 10,000 | 348,300 | 10,000 | |
| Jun 05 2019 | URGN | UroGen Pharma Ltd. | Nussbaum Ran | Director | Option Exercise | A | 34.83 | 10,000 | 348,300 | 10,000 | |
| Jun 05 2019 | URGN | UroGen Pharma Ltd. | Holden Stuart | Director | Option Exercise | A | 34.83 | 10,000 | 348,300 | 10,000 | |
| Jun 05 2019 | URGN | UroGen Pharma Ltd. | Belldegrun Arie | Director | Option Exercise | A | 34.83 | 10,000 | 348,300 | 10,000 | |
| Jun 05 2019 | URGN | UroGen Pharma Ltd. | Belldegrun Arie | Director | Option Exercise | A | 34.83 | 10,000 | 348,300 | 10,000 | |
| May 16 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,759 | 0 | 12,314 | |
| May 16 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Sell | S | 37.98 | 608 | 23,092 | 5,381 | 6 K to 5.4 K (-10.15 %) |
| May 16 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Buy | M | 0.00 | 1,759 | 0 | 5,989 | 4.2 K to 6 K (+41.58 %) |